World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT03397420
Date of registration: 02/01/2018
Prospective Registration: No
Primary sponsor: Elizabeth Glaser Pediatric AIDS Foundation
Public title: Family-centered HIV Care, Viral Suppression and Retention in HIV-positive Children, Swaziland FAM-CARE
Scientific title: Effect of Family-centered Model of HIV Care (FAM-CARE) on Viral Suppression and Retention in Care of HIV-positive Children in Swaziland
Date of first enrolment: September 13, 2017
Target sample size: 742
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT03397420
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Swaziland
Contacts
Name:     Caspian Chouraya, MD
Address: 
Telephone:
Email:
Affiliation:  Elizabeth Glaser Pediatric AIDS Foundation
Name:     Lynne Mofenson, MD
Address: 
Telephone:
Email:
Affiliation:  Elizabeth Glaser Pediatric AIDS Foundation
Name:     Nobuble Mthethwa, MD
Address: 
Telephone:
Email:
Affiliation:  Ministry of Health, Swaziland
Key inclusion & exclusion criteria

Inclusion Criteria:

- HIV-positive child aged <15 years receiving HIV care at the study facility.

Exclusion Criteria:

- At least one family member residing in the household is also HIV-positive and is
receiving services at the study facility



Age minimum: N/A
Age maximum: 14 Years
Gender: All
Health Condition(s) or Problem(s) studied
HIV Infections
Intervention(s)
Other: FAM-CARE
Primary Outcome(s)
Proportion of HIV-positive children on ART virally suppressed [Time Frame: 18 months after study enrollment.]
Proportion of HIV-positive on ART virally unsuppressed [Time Frame: 18 months after study enrollment.]
Secondary Outcome(s)
Factors associated with HIV viral suppression [Time Frame: 18 months after study enrollment]
Proportion HIV-positive children on ART virally suppressed (<1,000 copies/mL of HIV RNA) at 6 and 12 months after study enrollment [Time Frame: 6 and 12 months after study enrollment]
Acceptability of the FAM-CARE program based on individual interview responses [Time Frame: 18 months after study enrollment]
ART initiation [Time Frame: 18 months after study enrollment]
Loss to follow-up [Time Frame: 18 months after study enrollment]
Secondary ID(s)
EG0168
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
United States Agency for International Development (USAID)
Ministry of Health, Swaziland
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history